pembrolizumabubamatamabOvarian cancer
…o responses to ubamatamab did not correlate with sensitivity to pembrolizumab or chemotherapy, suggesting this therapy may benefit a distinct…
190articles mentioning drugs
566drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Pembrolizumab ×
Pembrolizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Pembrolizumab
190 articles · page 8 of 16Pembrolizumabadvanced melanomastage III/IV unresectable melanomaNCT05309421
…e. 16 patients with stage III/IV unresectable melanoma received Pembrolizumab and, 12 weeks later, treatment with six initial EVX-01 priming …
VAX014VAX014-relatednivolumabpembrolizumabDana-Farber Cancer InstituteDartmouth Hitchcock
…ved). The best overall response was SD (RECIST 1.1).Conclusions VAX014 monotherapy is well tolerated with evidence of activity in both…
TNG260pembrolizumabTNG260-inducedNSCLCNon-small cell lung cancerNCT05887492immune checkpoint-based therapies
…tial treatment strategy for patients with STK11-mutated tumors. TNG260 in combination with pembrolizumab is currently being evaluated …
pembrolizumabpembrolizumab-basedPD-1 inhibitorCCR8 antagonistGastric cancerFudan UniversityGCZhongshan Hospital
…nical outcomes but superior immunotherapeutic responsiveness to pembrolizumab in GC. Transcriptomic and phenotypic analyses revealed that tum…
pembrolizumabhead and neck squamous cell carcinomaHNSCC
…Background Immune checkpoint inhibitors such as pembrolizumab offer a therapeutic option for head and neck squamous cell carc…
pembrolizumabPNCT02818920NSCLCchemotherapy
…ncer (NSCLC) ( NCT02818920) evaluated the potential efficacy of pembrolizumab administration in the absence of chemotherapy. This communicati…
pembrolizumabhigh-dose intravenous methylprednisolonemelanomapneumonitis
…following hospital discharge, as a result of pneumonitis due to pembrolizumab.…
pembrolizumabECOG Performance StatusNSCLCPembro-real 5Y registry
…exity of long-term outcomes in patients with NSCLC treated with pembrolizumab, uncovering dynamic, non-linear prognostication trends. This an…
ipilimumablifileucelnivolumabLifileucel-induced
…en of nausea and vomiting was reported in patients treated with ipilimumab. 55From patient selection to TIL expansion: a comprehensive ove…
pembrolizumabnon-small cell lung cancerNSCLC
…history of poorly differentiated NSCLC, previously treated with pembrolizumab, presented with recurrent ascites, profound anasarca, dizziness…
pembrolizumabcarboplatinpaclitaxelepirubicincyclophosphamiderituximabtriple-negative breast carcinoma (TNBC)neoadjuvant chemo-immunotherapy
…ocol (paclitaxel, carboplatin, epirubicin, cyclophosphamide and pembrolizumab). Following the sixth cycle, she developed refractory focal sei…